HCA
NYSE · Health Care
Hca Healthcare Inc
$501.69
-12.07 (-2.35%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 72.03B | 66.78B | 45.67B | 45.52B | 41.53B |
| Net Income | 6.46B | 5.39B | 6.16B | 5.77B | 6.59B |
| EPS | — | — | — | — | — |
| Profit Margin | 9.0% | 8.5% | 13.5% | 12.7% | 15.9% |
| Rev Growth | +7.9% | +7.9% | -2.3% | -6.2% | +21.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 56.20B | 56.20B | 6.78B | 6.50B | 6.52B |
| Total Equity | 1.04B | 1.04B | 53.39B | 60.36B | 55.17B |
| D/E Ratio | 54.20 | 54.20 | 0.13 | 0.11 | 0.12 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 14.79B | 13.03B | 10.84B | 12.17B | 10.43B |
| Free Cash Flow | — | — | 5.91B | 5.32B | 5.19B |